These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 10891378)
41. [Dialyzed leukocyte extracts for the treatment of recurrent and severe infections in pediatric patients with cellular immunodeficiency: 15 years of experience]. Ayala MC; González NM; Palacios G; Rivera-Morales LG; Rodríguez-Padilla C Rev Alerg Mex; 2019; 66(1):27-37. PubMed ID: 31013404 [TBL] [Abstract][Full Text] [Related]
42. Lawrence Transfer Factor: Transference of Specific Immune Memory by Dialyzable Leukocyte Extract from a CD8+ T Cell Line. Wang JF; Park AJ; Rendini T; Levis WR J Drugs Dermatol; 2017 Dec; 16(12):1198-1206. PubMed ID: 29240855 [TBL] [Abstract][Full Text] [Related]
43. Study of the immunopotentiator effects of dialyzable leukocyte extracts obtained out of leukocytes previously used for interferon production. Arala-Chaves MP; Porto MT; Kauppinen HL; Massa AA; Myllylä G Vox Sang; 1982 Nov; 43(5):233-42. PubMed ID: 6183830 [TBL] [Abstract][Full Text] [Related]
44. Cellular transcription factors involved in the regulation of HIV-1 gene expression. Gaynor R AIDS; 1992 Apr; 6(4):347-63. PubMed ID: 1616633 [No Abstract] [Full Text] [Related]
45. Transfer Factor: Myths and Facts. Macias AE; Guaní-Guerra E Arch Med Res; 2020 Oct; 51(7):613-622. PubMed ID: 32654883 [TBL] [Abstract][Full Text] [Related]
46. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part II. Reconstituting effects dialyzable leukocyte lysates. (Second of three parts). Schindler TE; Baram P Allergol Immunopathol (Madr); 1980; 8(2):125-9. PubMed ID: 7457287 [No Abstract] [Full Text] [Related]
47. Lymphocyte marker testing in relation to the clinical use of dialyzed leukocyte extract containing transfer factor (DLE-LTF). Peetoom F; Florey MJ Haematologia (Budap); 1980; 13(1-4):225-37. PubMed ID: 7250812 [No Abstract] [Full Text] [Related]
48. Consistency of a dialyzable leucocyte extract manufactured at GMP facilities by nuclear magnetic resonance spectroscopy. Herbert-Pucheta JE; López-Morales CA; Medina-Rivero E; Estrada-Parra S; Pérez-Tapia SM; Zepeda-Vallejo LG J Pharm Biomed Anal; 2021 Mar; 196():113940. PubMed ID: 33549874 [TBL] [Abstract][Full Text] [Related]
49. Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract Intended for Batch Release. Carballo-Uicab G; Linares-Trejo JE; Mellado-Sánchez G; López-Morales CA; Velasco-Velázquez M; Pavón L; Estrada-Parra S; Pérez-Tapia SM; Medina-Rivero E Molecules; 2019 Sep; 24(19):. PubMed ID: 31547184 [TBL] [Abstract][Full Text] [Related]